Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties

…, C Valcarce-Aspegren, M Guldbrandt…

Index: Madsen, Peter; Kodra, Janos T.; Behrens, Carsten; Nishimura, Erica; Jeppesen, Claus B.; Pridal, Lone; Andersen, Birgitte; Knudsen, Lotte B.; Valcarce-Aspegren, Carmen; Guldbrandt, Mette; Christensen, Inge T.; Jorgensen, Anker S.; Ynddal, Lars; Brand, Christian L.; Bagger, Morten Aa.; Lau, Jesper Journal of Medicinal Chemistry, 2009 , vol. 52, # 9 p. 2989 - 3000

Full Text: HTML

Citation Number: 25

Abstract

The aim of the work presented here was to design and synthesize potent human glucagon receptor antagonists with improved pharmacokinetic (PK) properties for development of pharmaceuticals for the treatment of type 2 diabetes. We describe the preparation of compounds with cyclic cores (5-aminothiazoles), their binding affinities for the human glucagon and GIP receptors, as well as affinities for rat, mouse, pig, dog, and monkey ...